NIH Radio Archive
November 2008 Audio Reports
A study provides new evidence that therapeutic doses of stimulant medications for attention deficit hyperactivity disorder (ADHD), do not cause chromosomal damage in humans.
A new large study could help guide treatment for lung cancer with the use of biomarkers, which are molecules found in the body that can signal an abnormal process or disease.
Two of the most common medications used to treat attention deficit
hyperactivity disorder (ADHD) do not appear to cause genetic
damage in children who take them as prescribed.
A genetic study sheds new light on possible treatment strategies
for the most common form of lung cancer.
They're the clinician researchers and medical scientists of
tomorrow. And for two days in early November, they gathered at
the NIH Clinical Center to learn from seasoned veterans and to
take measure of the shoes they would seek to fill some day.
A newly-updated book called Alzheimer's Disease: Unraveling
the Mystery is now available from the National Institute on Aging.  FREE MP3 audio reports from the National Institutes of Health, your reliable health information source. Questions? Contact: This page was last reviewed on
December 4, 2008
.
|
